Sarilumab Net cash Pipeline Total Price % base biz
REGN ... S200 -
5150 -
5244 5244
5100 -
S50 -
50
REGN REGN wldupilumab and sarilumab
■ Eylea ■ Praluent ■
Dupilumab
■ Sarikirnab ■ Net cash Pipeline
Source Bole Mean !ovenGlobalResearch estimates
NPV assumptions for marketed products
Each ... REGN's total NPV, with the pipeline
representing 5117/sh.
Valuation with
dupilumab
and sarilumab factored in
We incorporate
dupilumab
and sarilumab into our second scenario because of the
clinical success